Gregg Wagner
About Gregg Wagner
Gregg Wagner is a Senior Manager of Regulatory Affairs at StrideBio, Inc., where he has worked since 2019. He has a strong background in biotherapeutics and biomarkers, with expertise in oncology, immunology, and gut microbiome research.
Work at StrideBio
Gregg Wagner has served as the Senior Manager of Regulatory Affairs at StrideBio, Inc. since 2019. In this role, he is responsible for overseeing regulatory strategies and ensuring compliance with industry standards. His work is crucial in advancing the company's initiatives in biotherapeutics, particularly in the context of rare and orphan diseases. StrideBio, located in the Raleigh-Durham-Chapel Hill area, focuses on innovative gene therapies, and Wagner's expertise contributes to the development and regulatory approval processes for these therapies.
Education and Expertise
Gregg Wagner holds a Doctor of Philosophy (Ph.D.) in Medical and Molecular Genetics from Indiana University School of Medicine, which he earned from 2008 to 2013. He also completed a Clinical Pharmacology- Clinical Research Training Program at Duke University Graduate School. Additionally, he studied Biotech and Pharmaceutical Strategy at Duke University's Fuqua School of Business. Wagner's educational background equips him with a strong foundation in biotherapeutics and biomarkers, particularly for rare diseases, and he possesses extensive knowledge in oncology, immunology, and the gut microbiome.
Background
Prior to his current role at StrideBio, Gregg Wagner worked in various research and managerial positions. He served as a Graduate Student Research Associate at Indiana University School of Medicine from 2008 to 2013. Following this, he was a Postdoctoral Research Fellow at Duke University from 2013 to 2016. He then transitioned to Metabolon, Inc., where he worked as a Senior Study Director in Population Health, Discovery & Translational Sciences from 2016 to 2019. This diverse background in research and regulatory affairs has shaped his career in the biopharmaceutical sector.
Achievements
Throughout his career, Gregg Wagner has developed significant expertise in analyzing large metabolomic datasets using advanced statistical tools. He has generated actionable scientific insights and novel hypotheses that have contributed to the understanding of various diseases. Additionally, he has worked closely with Sales and Marketing teams to identify and cultivate business opportunities through direct consultations with researchers and physician scientists. His contributions have been instrumental in bridging the gap between scientific research and practical applications in the biopharmaceutical industry.